Mon, June 26, 2023

Andreas Argyrides Downgraded (UBX) to Hold and Decreased Target to $2 on, Jun 26th, 2023

Andreas Argyrides of Wedbush, Downgraded "Unity Biotechnology, Inc." (UBX) to Hold and Decreased Target from $3 to $2 on, Jun 26th, 2023.

Andreas has made no other calls on UBX in the last 4 months.



There are 5 other peers that have a rating on UBX. Out of the 5 peers that are also analyzing UBX, 0 agree with Andreas's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Andreas


  • Dylan Dupuis of "Roth MKM" Initiated at Strong Buy and Held Target at $10 on, Wednesday, May 31st, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $6 on, Friday, May 26th, 2023
  • Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Wednesday, May 10th, 2023
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, March 28th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, March 16th, 2023